ROIVANT SCIENCES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.22 USD | -1.62% |
|
+0.85% | -0.04% |
| 04-05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
| 04-04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 9.19B | - | |||||
| 694B | ||||||
| 593B | ||||||
| 371B | ||||||
| 331B | ||||||
| 290B |
